Serentis News
Most Popular Serentis Story
Emerging Drug Developers: Serentis
When Tim Sharpington looks across the landscape of biotechnology, it’s easy for him to find examples of the kind of company he’d most like to emulate. The UK’s Read more...
Latest Headlines
- August 12, 2008
- August 23, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
